Predictive Systems Toxicology.

In this review we address to what extent computational techniques can augment our ability to predict toxicity. The first section provides a brief history of empirical observations on toxicity dating back to the dawn of Sumerian civilization. Interestingly, the concept of dose emerged very early on, leading up to the modern emphasis on kinetic properties, which in turn encodes the insight that toxicity is not solely a property of a compound but instead depends on the interaction with the host organism. The next logical step is the current conception of evaluating drugs from a personalized medicine point of view. We review recent work on integrating what could be referred to as classical pharmacokinetic analysis with emerging systems biology approaches incorporating multiple omics data. These systems approaches employ advanced statistical analytical data processing complemented with machine learning techniques and use both pharmacokinetic and omics data. We find that such integrated approaches not only provide improved predictions of toxicity but also enable mechanistic interpretations of the molecular mechanisms underpinning toxicity and drug resistance. We conclude the chapter by discussing some of the main challenges, such as how to balance the inherent tension between the predicitive capacity of models, which in practice amounts to constraining the number of features in the models versus allowing for rich mechanistic interpretability, i.e., equipping models with numerous molecular features. This challenge also requires patient-specific predictions on toxicity, which in turn requires proper stratification of patients as regards how they respond, with or without adverse toxic effects. In summary, the transformation of the ancient concept of dose is currently successfully operationalized using rich integrative data encoded in patient-specific models.

[1]  Navdeep Jaitly,et al.  A Structure-Based Approach for Mapping Adverse Drug Reactions to the Perturbation of Underlying Biological Pathways , 2010, PloS one.

[2]  Tingjun Hou,et al.  ADMET evaluation in drug discovery: 15. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling , 2016, Journal of Cheminformatics.

[3]  Roded Sharan,et al.  Combining Drug and Gene Similarity Measures for Drug-Target Elucidation , 2011, J. Comput. Biol..

[4]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[5]  B. Petrovska,et al.  Historical review of medicinal plants’ usage , 2012, Pharmacognosy reviews.

[6]  V. Chelliah,et al.  The promises of quantitative systems pharmacology modelling for drug development , 2016, Computational and structural biotechnology journal.

[7]  Paul Flecknell,et al.  Replacement, reduction and refinement. , 2002, ALTEX.

[8]  Ben Y. Reis,et al.  Predicting Adverse Drug Events Using Pharmacological Network Models , 2011, Science Translational Medicine.

[9]  Jean-Pierre Lepoittevin,et al.  Allergic contact dermatitis caused by naturally occurring quinones , 1991, Pharmaceutisch Weekblad.

[10]  Nina Jeliazkova,et al.  AMBIT RESTful web services: an implementation of the OpenTox application programming interface , 2011, J. Cheminformatics.

[11]  Andrew L. Hopkins,et al.  Drug discovery: Predicting promiscuity , 2009, Nature.

[12]  R. Sharan,et al.  PREDICT: a method for inferring novel drug indications with application to personalized medicine , 2011, Molecular systems biology.

[13]  Andreas Bender,et al.  ARWAR: A network approach for predicting Adverse Drug Reactions , 2016, Comput. Biol. Medicine.

[14]  Hongkang Mei,et al.  Systematic Prediction of Pharmacodynamic Drug-Drug Interactions through Protein-Protein-Interaction Network , 2013, PLoS Comput. Biol..

[15]  Yuanjia Hu,et al.  Network Analysis of Drug–target Interactions: A Study on FDA-approved New Molecular Entities Between 2000 to 2015 , 2017, Scientific Reports.

[16]  Günter Klambauer,et al.  DeepTox: Toxicity Prediction using Deep Learning , 2016, Front. Environ. Sci..

[17]  William J Jusko,et al.  Diversity of mechanism-based pharmacodynamic models. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[18]  Nina Jeliazkova,et al.  Toxmatch--a chemical classification and activity prediction tool based on similarity measures. , 2008, Regulatory toxicology and pharmacology : RTP.

[19]  R. M. Muir,et al.  Correlation of Biological Activity of Phenoxyacetic Acids with Hammett Substituent Constants and Partition Coefficients , 1962, Nature.

[20]  Yeyejide A. Adeleye,et al.  Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment. , 2015, Toxicology.

[21]  Mark T D Cronin,et al.  A review of the use of in silico methods to predict the chemistry of molecular initiating events related to drug toxicity , 2011, Expert opinion on drug metabolism & toxicology.

[22]  Anna Guryanova,et al.  sbv IMPROVER: Modern Approach to Systems Biology. , 2017, Methods in molecular biology.

[23]  Hector Zenil,et al.  Methods of information theory and algorithmic complexity for network biology. , 2014, Seminars in cell & developmental biology.

[24]  Xin Li,et al.  Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach , 2012, BMC Systems Biology.

[25]  Ruth Huey,et al.  Computational protein–ligand docking and virtual drug screening with the AutoDock suite , 2016, Nature Protocols.

[26]  P. Bork,et al.  Systematic identification of proteins that elicit drug side effects , 2013, Molecular systems biology.

[27]  F. Azuaje,et al.  Drug-target network in myocardial infarction reveals multiple side effects of unrelated drugs , 2011, Scientific reports.

[28]  H. Kitano Systems Biology: A Brief Overview , 2002, Science.

[29]  D. K. Arrell,et al.  Network Systems Biology for Drug Discovery , 2010, Clinical pharmacology and therapeutics.

[30]  George Kurian,et al.  Google's Neural Machine Translation System: Bridging the Gap between Human and Machine Translation , 2016, ArXiv.

[31]  Sunghoon Kim,et al.  Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug , 2012, BMC Systems Biology.

[32]  Lin He,et al.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..

[33]  Thomas Hartung,et al.  Food for thought ... on globalisation of alternative methods. , 2007, ALTEX.

[34]  Philip Hunter,et al.  A toxic brew we cannot live without , 2008, EMBO reports.

[35]  Ruth Nussinov,et al.  Structure and dynamics of molecular networks: A novel paradigm of drug discovery. A comprehensive review , 2012, Pharmacology & therapeutics.

[36]  K R Przybylak,et al.  Hepatotoxicity: A scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action , 2013, Critical reviews in toxicology.

[37]  Pantelis Sopasakis,et al.  Collaborative development of predictive toxicology applications , 2010, J. Cheminformatics.

[38]  J. Irwin,et al.  Lead discovery using molecular docking. , 2002, Current opinion in chemical biology.

[39]  C. Dobson Chemical space and biology , 2004, Nature.

[40]  Byunghan Lee,et al.  Deep learning in bioinformatics , 2016, Briefings Bioinform..

[41]  R. Altman,et al.  Integrating systems biology sources illuminates drug action , 2014, Clinical pharmacology and therapeutics.

[42]  Thomas Hartung,et al.  Lessons Learned from Alternative Methods and their Validation for a New Toxicology in the 21st Century , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[43]  Hao Ding,et al.  Similarity-based machine learning methods for predicting drug-target interactions: a brief review , 2014, Briefings Bioinform..

[44]  Vladimir B Bajic,et al.  In silico toxicology: computational methods for the prediction of chemical toxicity , 2016, Wiley interdisciplinary reviews. Computational molecular science.

[45]  Frank R. Burden,et al.  Relevance Vector Machines: Sparse Classification Methods for QSAR , 2015, J. Chem. Inf. Model..

[46]  J. Chen,et al.  Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures , 2013, Proteomics.

[47]  Ping Zhang,et al.  Exploring the associations between drug side-effects and therapeutic indications , 2014, J. Biomed. Informatics.

[48]  P. Aloy,et al.  Unveiling the role of network and systems biology in drug discovery. , 2010, Trends in pharmacological sciences.

[49]  Sebastian Thrun,et al.  Dermatologist-level classification of skin cancer with deep neural networks , 2017, Nature.

[50]  Jian Wang,et al.  In Silico Elucidation of the Molecular Mechanism Defining the Adverse Effect of Selective Estrogen Receptor Modulators , 2007, PLoS Comput. Biol..

[51]  Hector Zenil,et al.  A perspective on bridging scales and design of models using low-dimensional manifolds and data-driven model inference , 2016, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[52]  Robert P. Sheridan,et al.  Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..

[53]  Chang Liu,et al.  Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization , 2013, J. Chem. Inf. Model..

[54]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[55]  Hector Zenil,et al.  A Decomposition Method for Global Evaluation of Shannon Entropy and Local Estimations of Algorithmic Complexity , 2016, Entropy.

[56]  A. Barabasi,et al.  Network-based in silico drug efficacy screening , 2016, Nature Communications.

[57]  I. Farkas,et al.  Signalogs: Orthology-Based Identification of Novel Signaling Pathway Components in Three Metazoans , 2011, PloS one.

[58]  Ruth Nussinov,et al.  Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.

[59]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[60]  Meindert Danhof,et al.  Systems pharmacology - Towards the modeling of network interactions. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[61]  Daniel R. Caffrey,et al.  Structure-based maximal affinity model predicts small-molecule druggability , 2007, Nature Biotechnology.

[62]  Kriston L. McGary,et al.  Systematic discovery of nonobvious human disease models through orthologous phenotypes , 2010, Proceedings of the National Academy of Sciences.

[63]  Xiaobo Zhou,et al.  Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.

[64]  M. Ghert,et al.  Lost in translation: animal models and clinical trials in cancer treatment. , 2014, American journal of translational research.

[65]  P. Baldi,et al.  Searching for exotic particles in high-energy physics with deep learning , 2014, Nature Communications.

[66]  Saumitra Das,et al.  Interplay between NS3 protease and human La protein regulates translation-replication switch of Hepatitis C virus , 2011, Scientific reports.

[67]  Sherry L. Jenkins,et al.  Network analysis of FDA approved drugs and their targets. , 2007, The Mount Sinai journal of medicine, New York.

[68]  David Vidal,et al.  The In Vitro Pharmacological Profile of Drugs as a Proxy Indicator of Potential In Vivo Organ Toxicities. , 2016, Chemical research in toxicology.

[69]  Liang Zhao,et al.  Mapping the human toxome by systems toxicology. , 2014, Basic & clinical pharmacology & toxicology.

[70]  Emilio Benfenati,et al.  Comparison and Possible Use of In Silico Tools for Carcinogenicity Within REACH Legislation , 2011, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[71]  S. J. Campbell,et al.  Visualizing the drug target landscape. , 2010, Drug discovery today.

[72]  Eva Schlede,et al.  Development and Prevalidation of a List of Structure–Activity Relationship Rules to be Used in Expert Systems for Prediction of the Skin-sensitising Properties of Chemicals , 2004, Alternatives to laboratory animals : ATLA.

[73]  Narsis A Kiani,et al.  Systems Toxicology: Systematic Approach to Predict Toxicity. , 2016, Current pharmaceutical design.

[74]  Ann M. Richard,et al.  DSSTox chemical-index files for exposure-related experiments in ArrayExpress and Gene Expression Omnibus: enabling toxico-chemogenomics data linkages , 2009, Bioinform..

[75]  David S. Goodsell,et al.  A semiempirical free energy force field with charge‐based desolvation , 2007, J. Comput. Chem..

[76]  Gary W Caldwell,et al.  ADME optimization and toxicity assessment in early- and late-phase drug discovery. , 2009, Current topics in medicinal chemistry.

[77]  Baldomero Oliva,et al.  GUILDify: a web server for phenotypic characterization of genes through biological data integration and network-based prioritization algorithms , 2014, Bioinform..

[78]  Nick Plant,et al.  An introduction to systems toxicology , 2015 .

[79]  Yoshihiro Yamanishi,et al.  Predicting drug side-effect profiles: a chemical fragment-based approach , 2011, BMC Bioinformatics.

[80]  Inna Kuperstein,et al.  Network-based approaches for drug response prediction and targeted therapy development in cancer. , 2015, Biochemical and biophysical research communications.

[81]  J. Mestres,et al.  Drug‐Target Networks , 2010, Molecular informatics.

[82]  C. Tannert,et al.  High-Throughput Omics Technologies: Potential Tools for the Investigation of Influences of EMF on Biological Systems , 2009, Current genomics.

[83]  H. Yabuuchi,et al.  Analysis of multiple compound–protein interactions reveals novel bioactive molecules , 2011, Molecular systems biology.

[84]  Jie Shen,et al.  Comparison of Cramer classification between Toxtree, the OECD QSAR Toolbox and expert judgment. , 2015, Regulatory toxicology and pharmacology : RTP.

[85]  Shiwen Zhao,et al.  A co-module approach for elucidating drug-disease associations and revealing their molecular basis , 2012, Bioinform..

[86]  Tim Chapman Lab automation and robotics: Automation on the move , 2003, Nature.

[87]  Elena Marchiori,et al.  Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..

[88]  M. Schroeder,et al.  Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network. , 2012, Integrative biology : quantitative biosciences from nano to macro.

[89]  Mohieddin Jafari,et al.  Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database , 2015, Briefings Bioinform..

[90]  Gilles Clermont,et al.  Computational disease modeling – fact or fiction? , 2009, BMC Systems Biology.

[91]  Laetitia Martin-Chanas,et al.  Identify drug repurposing candidates by mining the Protein Data Bank , 2011, Briefings Bioinform..

[92]  Darrell R Abernethy,et al.  Systems pharmacology to predict drug toxicity: integration across levels of biological organization. , 2013, Annual review of pharmacology and toxicology.

[93]  Guigang Zhang,et al.  Deep Learning , 2016, Int. J. Semantic Comput..

[94]  Lucila Ohno-Machado,et al.  Making it personal: translational bioinformatics , 2013, J. Am. Medical Informatics Assoc..

[95]  Donald E. Mager,et al.  A Mechanism-Based PK/PD Model for Hematological Toxicities Induced by Antibody-Drug Conjugates , 2017, The AAPS Journal.

[96]  Jukka-Pekka Onnela,et al.  Community Structure in Time-Dependent, Multiscale, and Multiplex Networks , 2009, Science.

[97]  A. Butte,et al.  Predicting Adverse Drug Reactions Using Publicly Available PubChem BioAssay Data , 2011, Clinical pharmacology and therapeutics.

[98]  P. Bork,et al.  Network Neighbors of Drug Targets Contribute to Drug Side-Effect Similarity , 2011, PloS one.

[99]  Zhi-Pei Liang,et al.  High‐resolution 1H‐MRSI of the brain using SPICE: Data acquisition and image reconstruction , 2016, Magnetic resonance in medicine.

[100]  Hector Zenil,et al.  Evaluating Network Inference Methods in Terms of Their Ability to Preserve the Topology and Complexity of Genetic Networks , 2015, Seminars in cell & developmental biology.

[101]  Sanjay Joshua Swamidass,et al.  Mining small-molecule screens to repurpose drugs , 2011, Briefings Bioinform..

[102]  Yoshihiro Yamanishi,et al.  Drug Side-Effect Prediction Based on the Integration of Chemical and Biological Spaces , 2012, J. Chem. Inf. Model..

[103]  P. Bork,et al.  Drug discovery in the age of systems biology: the rise of computational approaches for data integration. , 2012, Current opinion in biotechnology.

[104]  David Vidal,et al.  Large-Scale Predictive Drug Safety: From Structural Alerts to Biological Mechanisms. , 2015, Chemical research in toxicology.